Patent ID: 11945826
Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Field: Organic fine chemistry (Chemistry)
Classification: CPC C | IPC C

Claim 9:
10. A crystalline form of (R)-3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-2-ethyl-7-hydroxy-2,3-dihydropyrido[2,3-f][1,4]oxazepin-4(5H)-yl)methyl)-4-methylphenyl)propanoic acid besylate salt, or a tautomer thereof, having an x-ray powder diffraction pattern comprising peaks at 25.18°, 22.53°, 16.66°, and 7.82°±0.2° 2θ as measured by x-ray powder diffraction using an x-ray wavelength of 1.5406 Å.